Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea

Transient Tachypnoea of the Newborn Clinical Trial

Official title: Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea

Status Completed

Clinical Trial Summary

In this study we will prospectively analyze the benefit of inhaled furosemide for preterm and term neonates with Transient Tachypnoea.

Clinical Trial Description

In this study we will prospectively analyze the benefit of inhaled furosemide for preterm and term neonates with transient Tachypnoea. Patients received nebulised Furosemide iv solution 1 mg/kg or nebulised 0,9% saline (4x/d) under blind conditions in random order so long as need a CPAP-treatment but max. 3 days. 20 Patient will be treating.

The benefit will be measured as reduction of dyspnea, respiratory rate, oxygen demand and time on CPAP. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Tachypnea
• Transient Tachypnea of the Newborn
• Transient Tachypnoea of the Newborn

• NCT number: NCT01407848
• Study type: Interventional
• Source: University of Cologne
• Status: Completed
• Phase: Phase 2
• Start date: January 2012
• Completion date: July 2015